Muhammad Furqan

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Gilead
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    GSK
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Immunocore
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Inbrx
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Incyte
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Jacobio
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Lilly
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Mirati
    Date added:
    03/20/2024
    Date updated:
    03/20/2024

Pages

Return to Iowa Hematology Oncology Conference: Emphasis on Precision-Guided Management